Expert Ratings For Beam Therapeutics
Expert Ratings For Beam Therapeutics
Beam Therapeutics 的专家评级
In the latest quarter, 5 analysts provided ratings for Beam Therapeutics (NASDAQ:BEAM), showcasing a mix of bullish and bearish perspectives.
在最近一个季度中，有5位分析师为Beam Therapeutics（纳斯达克股票代码：BEAM）提供了评级，显示了看涨和看跌的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.2, a high estimate of $57.00, and a low estimate of $35.00. This current average reflects an increase of 52.32% from the previous average price target of $30.33.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为46.2美元，最高估计为57.00美元，低估值为35.00美元。目前的平均价格比之前的平均目标股价30.33美元上涨了52.32％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The standing of Beam Therapeutics among financial...
通过对近期分析...
登录免费看全文
登录/注册